Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
1.
Sci Rep ; 13(1): 21068, 2023 11 29.
Article in English | MEDLINE | ID: mdl-38030672

ABSTRACT

Plankton are key ecological indicators for assessing the impacts of human-induced pressures like climate change and waste-water discharge. Here, 26 years (1988-2015) of biweekly in-situ chlorophyll-a concentration, mesozooplankton biomass and remotely-sensed sea surface temperature (SST) data are utilized to investigate long-term changes of plankton biomass and timing of growth (phenology) in relation to warming, in a coastal region of the Saronikos Gulf (Aegean Sea). A Waste-Water Treatment Plant (WWTP) was established in 1995, leading to decreased nutrient concentrations circa 2004. Overall, the results indicate an interplay between warming and changes in ecological status. During higher nutrient input (1989-2004), a temporal mismatch between zooplankton and phytoplankton, and a positive zooplankton growth-SST association, are evident. Conversely, in the warmer, less mesotrophic period 2005-2015, an earlier timing of zooplankton growth (related to copepod abundance) synchronizes with phytoplankton growth, including a secondary autumn growth period. Concurrently, an abrupt negative interannual relationship between SST and mesozooplankton, and a summer biomass decrease (linked with cladoceran abundance) are observed. This work provides evidence that current warming could alter plankton abundance and phenology in nearshore Eastern Mediterranean ecosystems, suggesting shifts in plankton community composition that could trigger potential cascading effects on higher trophic levels.


Subject(s)
Ecosystem , Plankton , Animals , Humans , Food Chain , Phytoplankton , Zooplankton , Biomass
2.
Br J Dermatol ; 176(1): 212-215, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27105586

ABSTRACT

Generalized pustular psoriasis (GPP) is a severe type of psoriasis accompanied by systemic and often life-threatening manifestations. The efficacy of the interleukin (IL)-1 antagonist anakinra in cases of GPP underscores the role of IL-1 in disease pathogenesis. We present a case of a middle-aged man who developed an abrupt and severe form of GPP with severe eosinophilia and cholestatic hepatitis. The patient received salvage treatment with a combination of glucocorticoids, hydroxyurea and imatinib, while administration of the IL-1 inhibitor anakinra resulted in remission of hepatitis and a significant skin improvement. However, due to persistent hypersensitivity skin reactions, anakinra was withdrawn and replaced with the anti-IL-1ß antagonist canakinumab. As a result of canakinumab, the patient's skin completely cleared, while no systemic manifestations recurred. After 1 year of continuous canakinumab therapy, the patient remained virtually free of symptoms, while the drug was well tolerated.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Dermatologic Agents/therapeutic use , Interleukin 1 Receptor Antagonist Protein/therapeutic use , Interleukin-1beta/antagonists & inhibitors , Psoriasis/drug therapy , Antibodies, Monoclonal, Humanized , Humans , Male , Middle Aged , Psoriasis/chemically induced , Treatment Outcome
4.
Nanoscale ; 8(26): 12869-73, 2016 Jul 14.
Article in English | MEDLINE | ID: mdl-27314986

ABSTRACT

The amplification of light in NIR-II from Ag2S QDs via metal enhanced fluorescence (MEF) is reported for the first time. Significant fluorescence enhancement of over 100 times for Ag2S QDs deposited on Au-nanostructured arrays, paves the way for novel sensing and imaging applications based on Ag2S QDs, with improved detection sensitivity and contrast enhancement.

5.
Bone Marrow Transplant ; 50(2): 232-6, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25365066

ABSTRACT

We retrospectively analyzed the impact of HLA-DPB1 mismatches in a large cohort of 1342 French patients who underwent 10/10 HLA-matched unrelated HSCT. A significant impact of HLA-DPB1 allelic mismatches (2 vs 0) was observed in severe acute GVHD (aGVHDIII-IV) (risk ratio (RR)=1.73, confidence interval (CI) 95% 1.09-2.73, P=0.019) without impact on OS, TRM, relapse and chronic GVHD (cGVHD). According to the T-cell epitope 3 (TCE3)/TCE4 HLA-DPB1 disparity algorithm, 37.6% and 58.4% pairs had nonpermissive HLA-DPB1, respectively. TCE3 and TCE4 disparities had no statistical impact on OS, TRM, relapse, aGVHD and cGVHD. When TCE3/TCE4 disparities were analyzed in the graft-vs-host or host-vs-graft (HVG) direction, only a significant impact of TCE4 nonpermissive disparities in the HVG direction was observed on relapse (RR=1.34, CI 95% 1.00-1.80, P=0.048). In conclusion, this French retrospective study shows an adverse prognosis of HLA-DPB1 mismatches (2 vs 0) on severe aGVHD and of nonpermissive TCE4 HVG disparities on relapse after HLA-matched 10/10 unrelated HSCT.


Subject(s)
Algorithms , HLA-DP beta-Chains , Hematologic Neoplasms/therapy , Hematopoietic Stem Cell Transplantation , Unrelated Donors , Adolescent , Adult , Aged , Allografts , Child , Child, Preschool , Female , France , Graft vs Host Disease/mortality , Graft vs Host Disease/prevention & control , Hematologic Neoplasms/mortality , Host vs Graft Reaction , Humans , Male , Middle Aged
6.
Pathol Biol (Paris) ; 61(1): 17-20, 2013 Jan.
Article in French | MEDLINE | ID: mdl-23399412

ABSTRACT

In the 1990 s, the variability of responses to human immunodeficiency virus (HIV) could only be tracked by phenotypic criteria such as the number of CD4T lymphocytes, the occurrence of opportunistic infection, the disease free survival without treatment. In 1996, the viral load is the leading phenotype for genetic studies. Ever since, thanks to a better understanding of the HIV infection pathophysiology, numerous studies helped to highlight the influence of genetic variability on inter-individual response to this virus. Among the genes having an impact, we can quote the following examples: CCR5, HLA-B and HLA-C genes. Practical applications of genetics in clinical medicine include search for HLA-B*57:01 before abacavir introduction. Recently, an eradicating treatment for HIV disease after bone marrow transplantation with a donor homozygote for a CCR5 gene non-functional variant (CCR5Δ32) has been reported. Interest in genetics of chronic viral infection is not specific to HIV. It has also been used on other viral diseases and it has gained a major place on the management of diseases.


Subject(s)
HIV Infections/genetics , Host-Pathogen Interactions/genetics , Disease Progression , Genes, MHC Class I/physiology , Genetic Predisposition to Disease , HIV Infections/immunology , HIV-1/immunology , HIV-1/metabolism , HIV-1/physiology , Host-Pathogen Interactions/immunology , Humans , Receptors, CCR5/genetics , Receptors, CCR5/metabolism
7.
J Infect Dis ; 205(5): 718-24, 2012 Mar 01.
Article in English | MEDLINE | ID: mdl-22238471

ABSTRACT

We performed a genome-wide association study comparing a cohort of 144 human immunodeficiency virus (HIV type 1-infected, untreated white long-term nonprogressors (LTNPs) with a cohort of 605 HIV-1-infected white seroconverters. Forty-seven single-nucleotide polymorphisms (SNPs), located from class I to class III major histocompatibility complex (MHC) subregions, show statistical association (false discovery rate, <0.05) with the LTNP condition, among which 5 reached genome-wide significance after Bonferonni correction. The MHC LTNP-associated SNPs are ordered in ≥4 linkage disequilibrium blocks; interestingly, an MHC class III linkage disequilibrium block (defined by the rs9368699 SNP) seems specific to the LTNP phenotype.


Subject(s)
Disease Progression , Genes, MHC Class I/genetics , HIV Infections/genetics , HIV-1 , Polymorphism, Single Nucleotide , DNA-Binding Proteins/genetics , Gene Frequency , Genome-Wide Association Study , Histocompatibility Antigens Class I/genetics , Humans , Major Histocompatibility Complex/genetics , RNA, Long Noncoding , RNA, Untranslated , Time Factors , Transcription Factors/genetics
8.
HIV Med ; 11(4): 239-44, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20050936

ABSTRACT

OBJECTIVE: The aim of the study was to determine whether the chemokine (C-C motif) receptor 5 (CCR5) Delta32 deletion is associated with long-term response to combination antiretroviral treatment (cART) in HIV-1-infected patients. METHODS: The genetic substudy of the Agence Nationale de Recherche sur le SIDA (ANRS) CO8 APROCO-COPILOTE cohort included 609 patients who started protease inhibitor-containing cART in 1997-1999. Patients were considered to have a sustained virological response if all plasma HIV RNA measurements in the period considered were <500 HIV-1 RNA copies/ml, allowing for a single blip. Virological response was compared between patients heterozygous for CCR5 Delta32 (Delta32/wt) and wild-type patients (wt/wt) from month 4 to year 3 and from month 4 to year 5. Logistic regression analysis was used to adjust for baseline demographical data, HIV RNA, CD4 cell count, antiretroviral exposure status, time spent on antiretroviral therapy at years 3 and 5 and adherence to treatment (month 4 to year 3 or 5). RESULTS: A sustained virological response was more frequent in Delta32/wt than in wt/wt patients from month 4 to year 3, with 66%vs. 52% of patients, respectively, showing a sustained response (P=0.02); after adjustment for potential confounders, the association of Delta32 with a sustained response was nearly significant (P=0.07). A sustained virological response was also more frequent in Delta32/wt patients up to year 5, with 48% showing a sustained response vs. 35% of wt/wt patients (P=0.01); after adjustment, Delta32 remained significantly associated with a sustained virological response up to year 5 (P=0.04). There was no association with CD4 response. CONCLUSION: The Delta32 deletion in Delta32/wt patients is associated with a beneficial virological response to cART in the long term. Whether this association is a direct effect of the Delta32 deletion remains unclear and requires confirmation in further observational studies.


Subject(s)
HIV Infections/genetics , HIV Protease Inhibitors/therapeutic use , HIV-1 , Receptors, CCR5/genetics , Adult , Age Factors , Alleles , Antiretroviral Therapy, Highly Active/methods , CD4 Lymphocyte Count , Female , Gene Deletion , HIV Infections/drug therapy , HIV Infections/virology , HIV-1/drug effects , HIV-1/genetics , Humans , Logistic Models , Male , Multivariate Analysis , Polymerase Chain Reaction , Prospective Studies , RNA, Viral/blood , Receptors, CCR5/immunology , Treatment Outcome
9.
Hippokratia ; 12(3): 188-90, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18923749

ABSTRACT

A 43 year old female patient presented for recurrent bacterial lower respiratory infections. A research for immunodeficiency status revealed total hypogammaglobulinemia, reduced IgG1, IgG2, IgG3 subclass levels, and low number of B lymphocytes (CD19+). Common Variable Immunodeficiency (CVID) 11.2 category was diagnosed according to recent criteria of primary immunodeficiencies (PID). Further immunological study consisting of genetic polymorphism of genes relating to differentiation, activation and function of B cells (ICOS, BAFF receptor BCMA and TACI) was performed, which did not reveal any related mutations. T cell parameters and Th1/Th2 cytokine network did not show any disturbances. It is postulated that probable endstage B cell differentiation defects should be investigated. The patient receives IVIGs replacement thereafter and the rate and severity of infections have significantly improved.

10.
Int J Immunogenet ; 34(5): 325-35, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17845302

ABSTRACT

Mutations in the human CC chemokine receptor 5 (CCR5) gene may alter the expression or function of the protein product, thereby altering chemokine binding/signalling or human immunodeficiency virus type 1 (HIV-1) infection of the cells that normally express CCR5 protein. We performed a systematic survey of natural sequence variations in an 8.1-kb region of the entire CCR5 gene as well as CCR2V64I in 50 Japanese subjects and evaluated the effects of those variations on CCR5 promoter activity. We also analysed CCR5 promoters and CCR2V64I in 80 more Japanese and 186 Thais. There was no 32-bp deletion observed in Caucasians, but two types of non-synonymous substitutions were found in CCR5 genes of Japanese. Our results showed several novel characteristics of the CCR2-CCR5 haplotype structure that were not reported from studies on Caucasians and African-Americans. Specifically, we were able to show that the G allele at position -2852 from the CCR5 open reading frame in Japanese and Thais is the representative of the CCR5 promoter haplotype that was reported to be associated with rapid progression to acquired immune deficiency syndrome (AIDS) in HIV-1-infected individuals. Furthermore, nearly all non-synonymous polymorphisms in Japanese CCR5 occurred in haplotypes with elevated promoter activity. We thus hypothesized that there was a certain selective pressure favouring low levels of CCR5 expression during human evolution.


Subject(s)
Acquired Immunodeficiency Syndrome/genetics , Asian People/genetics , HIV-1 , Polymorphism, Genetic , Receptors, CCR5/genetics , Alleles , Base Sequence , Disease Progression , Female , Gene Frequency , Haplotypes , Humans , Japan , Linkage Disequilibrium , Male , Molecular Sequence Data , Phylogeny , Polymorphism, Restriction Fragment Length , Promoter Regions, Genetic , Receptors, CCR5/classification
11.
HIV Med ; 8(4): 213-9, 2007 May.
Article in English | MEDLINE | ID: mdl-17461848

ABSTRACT

BACKGROUND: Patients heterozygous for the C-C chemokine receptor 5 (CCR5) Delta32 deletion spontaneously progress less rapidly to AIDS and death than do wild-type patients. We investigated whether the CCR5 Delta32 deletion has an impact on immunological, virological and clinical responses to highly active antiretroviral therapy (HAART) in HIV-1-infected patients. PATIENTS AND METHODS: We included in the study 565 HIV-1-infected patients from the French HIV-1 infected cohort with documented date of seroconversion (SEROCO)/haemophiliacs HIV-1 infected (HEMOCO) cohorts, who started HAART after 1996. We investigated virological responses to HAART at 6 months (defined as a plasma HIV-1 RNA measurement below the threshold of detection or a 2 log HIV-1 RNA decrease) and at 12 months (defined as a plasma HIV-1 RNA measurement below the threshold of detection) and clinical response to HAART by Kaplan-Meier survival curves, with AIDS and death as outcomes. RESULTS: The Delta32 heterozygous patients (n=83; 15%) had a better virological response to HAART than wild-type patients (73 vs 53% at 6 months, P=0.01; and 60 vs 44% at 12 months, P=0.01). This better virological response was still observed after adjustment for antiretroviral status (whether or not patients were naïve to antiretroviral therapy), year of HAART initiation, number of new antiretroviral drugs and baseline viral load. There was no statistical difference between heterozygous patients and wild-type patients in terms of survival and AIDS-free survival. CONCLUSIONS: CCR5 Delta32 heterozygous patients were more likely to have a virological response to HAART than wild-type patients at 6 and 12 months. However, this virological response did not produce better immunological and clinical responses. The long-term impact of the Delta32 deletion on survival in HIV-1-infected treated patients should be investigated in a meta-analysis.


Subject(s)
Antiretroviral Therapy, Highly Active/methods , HIV Infections/drug therapy , HIV-1/growth & development , Receptors, CCR5/genetics , Adult , Alleles , CD4 Lymphocyte Count , Cohort Studies , DNA/chemistry , DNA/genetics , Female , Gene Deletion , Genotype , HIV Infections/genetics , HIV Infections/immunology , HIV Infections/virology , Humans , Longitudinal Studies , Male , Polymerase Chain Reaction , RNA, Viral/blood , Receptors, CCR5/immunology , Viral Load
12.
Int J Immunogenet ; 33(2): 73-9, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16611250

ABSTRACT

Cytotoxic T lymphocytes (CTLs) play an essential role in the control of viral replication during human immunodeficiency virus (HIV) infection. However, the efficacy of the CTL response varies between individuals. We tested the hypothesis that genetic polymorphisms in the lytic effector molecule perforin could influence the progression of HIV infection. The perforin gene was screened for single nucleotide polymorphisms (SNPs) by denaturing high-performance liquid chromatography (dHPLC). Correlations were sought between perforin genotype, perforin expression and lytic function of CD8+ T lymphocytes from HIV-positive patients. Association of perforin genotype with disease progression was investigated in 426 seroconverters enrolled in the French SEROCO cohort. AIDS-free survival curves were constructed using the Kaplan-Meier method and compared using the log-rank test. Three SNPs were found in the proximal promoter region of the perforin gene: 63G (allelic frequency 0.029), 112G (allelic frequency 0.071) and 1012T (allelic frequency 0.070). The presence of the 1012T genotype correlated with fewer perforin+ cells among circulating CD8+ CTL. However, CTL lines from HIV(-positive) individuals heterozygous for the perforin 1012T SNP displayed normal lysis of target cells, and within the SEROCO cohort, patients heterozygous for the 1012T SNP showed normal disease progression. However, 1012T/T homozygotes showed a tendency towards slower disease progression (P = 0.08). In conclusion, polymorphism in the perforin gene is limited, and although the 1012T genotype appears to influence perforin expression, it was not conclusively associated with disease progression in HIV infection.


Subject(s)
HIV Infections/genetics , HIV , Membrane Glycoproteins/genetics , Polymorphism, Single Nucleotide , Promoter Regions, Genetic , Cytotoxicity, Immunologic/genetics , Disease Progression , Female , Genetic Carrier Screening , Genotype , HIV Infections/immunology , HIV Infections/metabolism , Humans , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/biosynthesis , Perforin , Pore Forming Cytotoxic Proteins , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Cytotoxic/metabolism , T-Lymphocytes, Cytotoxic/virology
13.
J Soc Biol ; 196(1): 7-11, 2002.
Article in French | MEDLINE | ID: mdl-12134637

ABSTRACT

The genetic control of HIV infection by the host involves a certain number of genes, among which those which code for chemokines/chemokines receptors, cytokines, MHC. Genes such as CCR5, CCR2, SDF1, and more recently CX3CR1 received great attention from several laboratories including ours, since they play a role as HIV coreceptor and, as such, on the infectivity of the host. In addition, it was shown that the polymorphism of these genes influences the evolution of infection, whether they have a protective or deleterious effect. Results obtained by our laboratory on the genetic polymorphism and its implication in HIV infection will be reported herein. Furthermore, to better understand their role, we looked for the capacities that the chemokines may have to play an immunomodulatory function, independently of their chemoattractive effect. In two examples, we showed that chemokines influence notably the cellular immune functions, such as CD8 cytotoxicity (Rantes/CCR3) and gamma interferon production (fractalkine/CX3CR1). Globally, the results indicate that chemokines/chemokines receptors polymorphism represent important epidemiological factors, but also contributes to evaluate the prognosis of HIV infection, through a better understanding of the disease physiopathology.


Subject(s)
Chemokines , HIV Infections/genetics , HIV Infections/immunology , Immunity , Chemokines/genetics , Chemokines/immunology , Genetic Predisposition to Disease , Humans , Immunity, Cellular , Polymorphism, Genetic , Receptors, Chemokine/genetics
14.
Ann Intern Med ; 135(9): 782-95, 2001 Nov 06.
Article in English | MEDLINE | ID: mdl-11694103

ABSTRACT

BACKGROUND: Studies relating certain chemokine and chemokine receptor gene alleles with the outcome of HIV-1 infection have yielded inconsistent results. OBJECTIVE: To examine postulated associations of genetic alleles with HIV-1 disease progression. DESIGN: Meta-analysis of individual-patient data. SETTING: 19 prospective cohort studies and case-control studies from the United States, Europe, and Australia. PATIENTS: Patients with HIV-1 infection who were of European or African descent. MEASUREMENTS: Time to AIDS, death, and death after AIDS and HIV-1 RNA level at study entry or soon after seroconversion. Data were combined with fixed-effects and random-effects models. RESULTS: Both the CCR5-Delta32 and CCR2-64I alleles were associated with a decreased risk for progression to AIDS (relative hazard among seroconverters, 0.74 and 0.76, respectively; P = 0.01 for both), a decreased risk for death (relative hazard among seroconverters, 0.64 and 0.74; P < 0.05 for both), and lower HIV-1 RNA levels after seroconversion (difference, -0.18 log(10) copies/mL and -0.14 log(10) copies/mL; P < 0.05 for both). Having the CCR5-Delta32 or CCR2-64I allele had no clear protective effect on the risk for death after development of AIDS. The results were consistent between seroconverters and seroprevalent patients. In contrast, SDF-1 3'A homozygotes showed no decreased risk for AIDS (relative hazard for seroconverters and seroprevalent patients, 0.99 and 1.03, respectively), death (relative hazard, 0.97 and 1.00), or death after development of AIDS (relative hazard, 0.81 and 0.97; P > 0.5 for all). CONCLUSIONS: The CCR5-Delta32 and CCR2-64I alleles had a strong protective effect on progression of HIV-1 infection, but SDF-1 3'A homozygosity carried no such protection.


Subject(s)
Chemokines, CXC/genetics , HIV Infections/genetics , HIV-1 , Receptors, CCR5/genetics , Receptors, Chemokine/genetics , Acquired Immunodeficiency Syndrome/genetics , Acquired Immunodeficiency Syndrome/mortality , Alleles , Chemokine CXCL12 , Disease Progression , HIV-1/genetics , Heterozygote , Humans , Proportional Hazards Models , RNA/metabolism , Receptors, CCR2 , Regression Analysis
16.
Gastroenterology ; 118(6): 1117-23, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10833486

ABSTRACT

BACKGROUND & AIMS: A common clinical issue is whether overweight patients with abnormal liver function test results should undergo liver biopsy. Although serious liver injury can occur, its prevalence and risk factors are not well known. METHODS: Ninety-three consecutive patients with abnormal liver function tests (but without overt liver disease), body mass index (BMI) > 25 kg/m(2), and no alcoholic, viral, autoimmune, drug-induced, or genetic liver disease were retrospectively studied. Clinical, biological, and histological variables were tested for association with septal fibrosis or cirrhosis. RESULTS: Septal fibrosis was present in 28 patients (30%) including cirrhosis in 10 (11%). Age >/= 50 years (odds ratio [OR], 14.1), BMI >/= 28 kg/m(2) (OR, 5.7), triglycerides >/= 1.7 mmol/L (OR, 5), and alanine aminotransferase (ALT) >/= 2N (OR, 4.6) were independently associated with septal fibrosis. Among histological features, septal fibrosis was strongly associated with necroinflammatory activity (OR, 44). A score combining age, BMI, triglycerides, and ALT had 100% negative predictive value for septal fibrosis when scoring 0 or 1 (100% sensitivity for a specificity of 47%). CONCLUSIONS: Septal fibrosis occurs frequently in overweight patients with abnormal liver function tests. A clinicobiological score combining BMI, age, ALT, and triglycerides could improve selection of patients for liver biopsy.


Subject(s)
Liver Cirrhosis/epidemiology , Liver Cirrhosis/pathology , Obesity/epidemiology , Obesity/pathology , Adult , Aged , Alanine Transaminase/blood , Biopsy , Disease Progression , Female , Follow-Up Studies , Humans , Liver Function Tests , Male , Middle Aged , Multivariate Analysis , Predictive Value of Tests , Prevalence , Retrospective Studies , Risk Factors
17.
Science ; 287(5461): 2274-7, 2000 Mar 24.
Article in English | MEDLINE | ID: mdl-10731151

ABSTRACT

Human immunodeficiency virus (HIV) enters cells in vitro via CD4 and a coreceptor. Which of 15 known coreceptors are important in vivo is poorly defined but may be inferred from disease-modifying mutations, as for CCR5. Here two single nucleotide polymorphisms are described in Caucasians in CX3CR1, an HIV coreceptor and leukocyte chemotactic/adhesion receptor for the chemokine fractalkine. HIV-infected patients homozygous for CX3CR1-I249 M280, a variant haplotype affecting two amino acids (isoleucine-249 and methionine-280), progressed to AIDS more rapidly than those with other haplotypes. Functional CX3CR1 analysis showed that fractalkine binding is reduced among patients homozygous for this particular haplotype. Thus, CX3CR1-I249 M280 is a recessive genetic risk factor in HIV/AIDS.


Subject(s)
Acquired Immunodeficiency Syndrome/physiopathology , Chemokines, CX3C , HIV Infections/physiopathology , Polymorphism, Single Nucleotide , Receptors, Cytokine/genetics , Receptors, Cytokine/physiology , Receptors, HIV/genetics , Receptors, HIV/physiology , Acquired Immunodeficiency Syndrome/genetics , Acquired Immunodeficiency Syndrome/virology , CX3C Chemokine Receptor 1 , Case-Control Studies , Chemokine CX3CL1 , Chemokines, CXC/metabolism , Chromosomes, Human, Pair 3 , Cohort Studies , Disease Progression , Genetic Variation , Genotype , HIV/physiology , HIV Infections/genetics , HIV Infections/virology , Haplotypes , Homozygote , Humans , Leukocytes, Mononuclear/metabolism , Linkage Disequilibrium , Membrane Proteins/metabolism , Mutation , Polymorphism, Restriction Fragment Length , Polymorphism, Single-Stranded Conformational , Survival Analysis , White People/genetics
18.
Am J Trop Med Hyg ; 61(3): 420-4, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10497983

ABSTRACT

To define the medical characteristics of intravascular drug users in Ho Chi Minh City, Vietnam, we examined 280 men, of whom 235 were infected with human immunodeficiency virus (HIV), being treated in a rehabilitation center. The patients used mainly opium, often in shooting galleries (50%). The prevalence of oral candidiasis (58%) and zoster infection (20%) was high in HIV-seropositive patients, whereas oral hairy leukoplasia and Kaposi's sarcoma were absent. The prevalence of acquired immunodeficiency syndrome was 24%. More than 80% of the patients had infections with hepatitis C virus, hepatitis B virus, cytomegalovirus, or human T cell lymphotropic virus type-1. The CD4+ cell counts correlated well with viral load. Only HIV-1 subtype E was detected in the 30 patients tested. A cohort study of HIV-infected subjects in this population seems feasible, and would permit introduction of anti-retroviral therapy The large number of HIV-seronegative subjects sharing the same at-risk practices as the HIV-infected subjects raises the possibility of natural protection in this population.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , HIV Infections/complications , HIV-1/isolation & purification , Substance Abuse, Intravenous/complications , Adult , CD4 Lymphocyte Count , CD8-Positive T-Lymphocytes , Cross-Sectional Studies , HIV Infections/immunology , HIV Infections/virology , HIV Seronegativity , HIV-1/classification , HIV-1/physiology , Humans , Lymphocyte Count , Male , Middle Aged , Prevalence , RNA, Viral/blood , Vietnam/epidemiology , Viral Load
19.
J Infect Dis ; 180(3): 920-4, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10438395

ABSTRACT

This study attempted to determine whether the CCR5 Delta32 deletion affected progression to certain first AIDS-defining illnesses in human immunodeficiency virus type 1-infected patients enrolled in the French SEROCO/HEMOCO/SEROGEST cohorts. Toxoplasmosis onset as a first AIDS-defining illness was significantly delayed in 253 heterozygous patients, compared with 1404 wild type patients. The relative risk of toxoplasmosis associated with heterozygosity was 0. 39 (95% confidence interval, 0.16-0.96) after adjustment for age, CD4 cell count, and primary specific prophylaxis. A nonsignificant protective trend was observed with regard to the onset of mycobacterial, cytomegalovirus, and herpesvirus diseases, but these events were less frequent than toxoplasmosis. Progression to other conditions (e.g., wasting, non-Hodgkin's lymphoma, Kaposi's sarcoma) was similar in the 2 groups as was the frequency of toxoplasmosis as a subsequent AIDS-defining illness. As chemokines are involved in numerous infectious processes, the Delta32 deletion could delay progression to certain opportunistic infections such as toxoplasmosis.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Acquired Immunodeficiency Syndrome/immunology , HIV Infections/immunology , Receptors, CCR5/genetics , Sequence Deletion , Toxoplasmosis/epidemiology , AIDS-Related Opportunistic Infections/immunology , Acquired Immunodeficiency Syndrome/genetics , Adult , CD4 Lymphocyte Count , Cohort Studies , Disease Progression , Follow-Up Studies , HIV Infections/genetics , HIV-1 , Humans , Risk Factors , Time Factors , Toxoplasmosis/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...